IRIDEX Corp (IRIX) stock

IRIXNasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends January 3

Financials through Q2 FY2026, quarter ended Jul 4, 2026Last filing: 10-Q on Aug 18, 2026Score 8/30

$0.69−0.02 (-2.75%)

Close on Nov 13, 2026Market cap $12.12MP/E –Yield –

Iridex statistics

83 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Q3 FY2026, expected soon
Last ex-dividend date: No dividends
Fundamentals through: Jul 4, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $12.12M; $498.53M
Enterprise Value: $7.44M; $433.11M
PS Ratio: 0.24; 2.94
PB Ratio: 3.33; 3.24
P/TBV Ratio: 6.55; 4.81

Enterprise valuationIndustry

EV / Sales: 0.14; 2.60

Share statisticsIndustry

Shares Outstanding: 18M; 43M
Shares Change (YoY): 3.31%; 3.32%
Shares Change (QoQ): 0.33%; 0.20%
Float: 4M; 37M
Shares Held by Insiders: 76.1%; 10.5%
Shares Held by Institutions: 12.4%; 60.5%

Short sellingIndustry

Short Interest: 39,421; –
Short Interest Change: -48.3%; -2.57%
Short % of Float: 0.94%; 5.11%
Short % of Shares Outstanding: 0.22%; 3.98%
Days to Cover: 1.58; 3.94

Stock price statisticsIndustry

52-Week High: $1.65; –
52-Week Low: $0.61; –
20-Day Moving Average: $0.72; –
50-Day Moving Average: $0.71; –
200-Day Moving Average: $1.00; –
Average True Range (14): $0.06; –
Price Change (1 Week): 4.96%; 0.99%
Price Change (1 Month): -16.3%; -3.52%
Price Change (3 Months): -21.6%; -7.86%
Price Change (6 Months): -31.7%; -1.12%
Price Change (YTD): -39.5%; -2.92%
Price Change (1 Year): -27.7%; -1.37%
Price Change (3 Years): -63.7%; 3.24%
Price Change (5 Years): -91.4%; -50.4%
Price Change (10 Years): -95.7%; 58.9%
Average Volume (10 Days): 28,680; –
Average Volume (20 Days): 26,139; –
Average Volume (90 Days): 293,042; –
Relative Volume: 0.02; 0.76
Relative Strength Index (14): 45.5; 46.7
Volatility (1 Year): 70.9%; 64.2%
Beta (5 Years): 0.93; 1.04

MarginsIndustry

Gross Margin: 35.9%; 55.9%
Operating Margin: -5.39%; -5.12%
Pretax Margin: -6.58%; -2.32%
Profit Margin: -6.88%; -9.29%
EBITDA Margin: -4.52%; -2.52%
FCF Margin: -3.88%; 0.65%

Returns on capitalIndustry

Return on Equity (ROE): -73.1%; -17.3%
Return on Assets (ROA): -12.1%; -12.3%
Return on Capital Employed (ROCE): -19.7%; -8.13%

Financial positionIndustry

Current Ratio: 1.82; 2.49
Quick Ratio: 0.79; 1.53

GrowthIndustry

Revenue Growth (YoY): 3.68%; 9.42%
Revenue Growth (3Y CAGR): -2.58%; 7.08%
Revenue Growth (5Y CAGR): 7.70%; 11.8%

EfficiencyIndustry

Asset Turnover: 1.75; 0.59
Inventory Turnover: 3.63; 2.20
Revenue Per Employee: $554.55K; $331.99K
Profits Per Employee: -$38.14K; -$46.47K
Employee Count: 93; 193
WACC: 9.75%; 9.91%

Income statement (TTM)Industry

Revenue: $51.57M; $108.17M
Gross Profit: $18.53M; $62.29M
Operating Income: -$2.78M; -$3.72M
Pretax Income: -$3.40M; -$1.83M
Net Income: -$3.55M; -$6.19M
EBITDA: -$2.33M; -$1.98M
EPS (Diluted): -$0.20; -$0.11

Balance sheetIndustry

Cash & Short-Term Investments: $4.68M; $38.97M
Net Cash (Debt): $4.68M; $3.95M
Net Cash Per Share: $0.27; $0.26
Equity (Book Value): $3.64M; $63.80M
Book Value Per Share: $0.21; $3.26
Tangible Book Value: $1.85M; $11.61M
Working Capital: $10.79M; $57.32M

Cash flow (TTM)Industry

Operating Cash Flow: -$1.73M; -$483.87K
Capital Expenditures: -$270.00K; -$3.94M
Free Cash Flow: -$2.00M; -$238.00K
FCF Per Share: -$0.11; -$0.00

Dividends and yieldsIndustry

Earnings Yield: -29.3%; -4.76%
FCF Yield: -16.5%; 0.28%

Taxes and interestIndustry

Income Tax: $152.00K; $1.55M

Scores and fair valueIndustry

Altman Z-Score: -2.50; 2.47
Piotroski F-Score: 5; 5
Beneish M-Score: -2.58; -2.64

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	IRIX	S&P 500	Difference	IRIX per year	S&P 500 per year
1 month	-18.7%	-3.0%	−15.6 pts
3 months	-16.3%	-2.8%	−13.5 pts
Year to date	-39.5%	+11.5%	−51.0 pts
1 year	-22.2%	+13.5%	−35.7 pts
3 years	-66.3%	+77.7%	−144.0 pts	-30.4%	+21.1%
5 years	-91.4%	+72.6%	−164.0 pts	-38.8%	+11.5%
10 years	-95.7%	+308.2%	−403.9 pts	-27.0%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M IRIX shares were sold short on Oct 30, 2026, down 48.3% from the previous report, or 0.94% of the shares available to trade. At recent volumes it would take 1.6 days to buy them back. Over the last 20 sessions, 23.8% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	39,421	-48.3%	24,978	1.6
Oct 15, 2026	76,195	-42.1%	1,950,126	1.0
Sep 30, 2026	131,655	-17.9%	37,757	3.5
Sep 15, 2026	160,330	+8.1%	62,584	2.6
Aug 31, 2026	148,311	+291.8%	150,642	1.0
Aug 14, 2026	37,854	+29.8%	53,710	1.0
Jul 31, 2026	29,164	-19.1%	59,439	1.0
Jul 15, 2026	36,062	+20.2%	30,868	1.2
Jun 30, 2026	29,995	+37.8%	46,956	1.0
Jun 15, 2026	21,768	-21.9%	77,286	1.0
May 29, 2026	27,882	-2.2%	71,617	1.0
May 15, 2026	28,508	-49.5%	48,115	1.0